logo
Two years after train derailment, NIH to commission longer-term health studies of East Palestine residents

Two years after train derailment, NIH to commission longer-term health studies of East Palestine residents

CNN19-06-2025

The National Institutes of Health said Thursday that it will fund longer-term health studies of the residents of East Palestine, Ohio, after a 2023 train derailment that sent more than a million pounds of hazardous chemicals into the soil, water and air.
The community has long asked the government to do more to help answer questions about the mental and physical effects of the disaster, which some people say they continue to struggle with more than two years later.
The funding will be available through the National Institute of Environmental Health Sciences.
In 2024, under the Biden administration, the institute funded six two-year rapid-response projects to study different aspects of exposures and health problems after the disaster. Those projects were worth more than $1 million in total.
The new grants will award up to $10 million for one to three projects over the next five years.
Vice President JD Vance, who was a senator from Ohio when the derailment occurred, pushed for the funding, the NIH said.
'NIH is working to ensure that the people of East Palestine and the surrounding communities are listened to, cared for, and get the answers they deserve,' NIH Director Dr. Jay Bhattacharya said in a news release. 'This multi-disciplinary research program will focus on public health tracking and surveillance of the community's health conditions to support health care decisions and preventive measures.'
East Palestine resident Misti Allison, who ran for mayor after the disaster and campaigned for long-term health studies in the area, said she was pleasantly surprised by the announcement. She sits on the board of one of the current community health studies.
'This next level of funding will enable us to conduct comprehensive and high-impact studies that can truly make a difference in the area,' Allison said.
She notes that the funding announcement mentions that the research will be co-developed with input from the community. 'This will really ensure that our concerns and needs are at the forefront,' she said. 'So that is really great.'
More than two years after the disaster, there's been a surge in post-traumatic stress disorder symptoms, respiratory complaints and even some cancers, Allison said. Because cancers have many causes, however, it's difficult to tie those directly to chemical exposures from the derailment, she noted.
Jessica Conard, whose son developed asthma a few months after breathing toxic fumes from the derailment, said the announcement brought 'a complicated mix of emotions.'
'We have had real symptoms now for 2½ years, and all we've received is gaslighting and dismissals from state, local and federal agencies,' Conard said.
'We still need an organized medical response, and this should have happened immediately after the disaster,' she said. 'This feels like a political afterthought.
'My hope is that this $10 million doesn't just fund another academic report that sits on the shelf without any actionable takeaways,' she said, 'We desperately need real medical support.'
Allison said the community has advocated for an emergency declaration to activate special provisions for victims of environmental exposures that would enable residents to receive Medicare benefits to help pay for their ongoing health needs.
'These funds would be a lifeline for many families who are still grappling with health concerns and some economic hardship,' she said.
Dr. Andrew Whelton, a civil and environmental engineer at Purdue University who helps communities assess the impacts of disasters, said the need for the funding is unfortunate. The government and community would have been better served if they'd made more money available up-front to prevent exposures to residents in the first place, he said, and inadequate indoor air testing allowed residents to be exposed to chemicals in their homes for months after the disaster.
'It's positive that there is funding to potentially help people investigate long-term health impact questions, but none of it would have been necessary if the right decisions were made and people in agencies didn't fail the public' in the first place, Whelton said.
The NIH said it will accept applications for the East Palestine study grants until July 21.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

West Nile Virus found in mosquitoes in Lubbock County, warns city. Here's what to know
West Nile Virus found in mosquitoes in Lubbock County, warns city. Here's what to know

Yahoo

time32 minutes ago

  • Yahoo

West Nile Virus found in mosquitoes in Lubbock County, warns city. Here's what to know

The City of Lubbock is warning Lubbock County residents that West Nile Virus has been detected in mosquitoes in the county. According to the city, the Biological Threat Research Lab at Texas Tech University has notified the Lubbock Health Department that mosquitoes carrying West Nile Virus are active in Lubbock County. Others are reading: What's coming in Lubbock County's proposed budget? Here's what's being discussed In response, the vector control teams will increase spraying within the community, with the city strongly urging the public to take precautions to reduce mosquito bites and help prevent the spread of the virus. The city is also asking residents to help prevent the spread of the virus by reporting biting adult mosquitoes or reporting a suspected mosquito breeding site. According to the health department, West Nile is a disease of birds that humans are exposed to after a mosquito has fed on an infected bird. Humans can only contract it from mosquitoes and cannot pass it to other humans. For more information about West Nile Virus, visit the CDC website: According to the health department, here are the common symptoms: Headache. Fever. Muscle and joint aches. Nausea. Fatigue. Symptoms involving the central nervous system can also develop, which include neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, and paralysis. According to the health department, most infected people show no symptoms, with most recovering on their own. Currently, there are no medications or vaccines to prevent or treat infection. People over 50 years old and those with other health issues are at a higher risk of becoming seriously ill. If people have symptoms and suspect West Nile Virus infection, they should contact their healthcare provider. Individuals can take the following steps to prevent infection this holiday week and throughout summer: Wearing an EPA-registered insect repellant Covering up with long-sleeved shirts and long pants Keeping mosquitoes out of living areas by using air conditioning or intact window screens Limiting outdoor activities during peak mosquito times Dumping standing water around your home As of June 18, there have been no reported human West Nile infection cases or deaths in Lubbock in 2025. Mateo Rosiles is the Government & Public Policy reporter for the Lubbock Avalanche-Journal. Got a news tip for him? Email him: mrosiles@ This article originally appeared on Lubbock Avalanche-Journal: West Nile Virus found in mosquitoes around Lubbock, city urges caution

Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results
Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results

Yahoo

time34 minutes ago

  • Yahoo

Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results

Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the 10 best healthcare penny stocks to buy according to analysts. The company's stock surged 12.1% on June 23 after it announced positive six-month follow-up results from an investigator-sponsored, first-in-human study of its type 1 diabetes treatment. A laboratory cultivating cells for the development of gene and cell therapies. The therapy in focus is UP421, which consists of cadaver-sourced pancreatic islet cells that have been genetically modified using Sana's hypoimmune (HIP) technology to evade immune detection. A significant finding is that the transplanted cells were safe, well-tolerated, survived, and continued to produce insulin in the patient without the need for immunosuppressive medicines. The study identified no safety issues, and the HIP-modified islet cells successfully evaded immune responses (both allogeneic and autoimmune). Per-Ola Carlsson, MD, Study Principal Investigator, Senior Physician, and Professor at the Clinic for Uppsala University Hospital, stated that the consistent results at four-week, 12-week, and now six-month follow-ups continue to suggest that a functional cure for type 1 diabetes without immunosuppression is possible. Sana Biotechnology, Inc. (NASDAQ:SANA) is a biotechnology company. It develops engineered cell therapies to treat serious diseases, aiming to repair or replace damaged cells. Its platforms include hypoimmune cells, gene delivery, and in vivo cell engineering. Sana's pipeline targets conditions like cancer, type 1 diabetes, and genetic disorders. While we acknowledge the potential of SANA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Energy Stocks: 10 Stocks to Buy and 10 Best AI Stocks to Buy According to Billionaire David Tepper. Disclosure: None.

Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells
Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells

Fox News

time38 minutes ago

  • Fox News

Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells

A potentially deadly fungus known as "pharaoh's curse fungus" could offer an unexpected path to fighting cancer, recent research shows. Scientists from the University of Pennsylvania modified molecules from the fungus — which is officially called Aspergillus flavus — to create a new compound and enhance its cancer-killing properties. "Fungi gave us penicillin," said Dr. Xue (Sherry) Gao, an associate professor at UPenn and leader of the study, in a press release. "These results show that many more medicines derived from natural products remain to be found." The findings were published in the journal Nature Chemical Biology. Aspergillus flavus is found in decaying leaves and compost, as well as on trees, plants and some crops, according to Mayo Clinic. While the fungus doesn't endanger most healthy people, it can cause respiratory issues for those who have weakened immune systems or are taking certain medications. Some of the more severe complications of the fungus can include bleeding in the lungs and life-threatening infections in the brain, heart and kidneys, Mayo Clinic stated. After archaeologists opened King Tut's tomb in the 1920s, multiple members of the excavation team died suddenly, fueling rumors of a "curse" upon those who dared interfere with the pharaoh's rest, according to the UPenn press release. Decades later, doctors hypothesized that fungal spores, which had been dormant for thousands of years, could have infected the team. In the 1970s, it happened again, the university stated. A dozen scientists entered another tomb, this time in Poland — and 10 died within a few weeks. Later investigations were said to reveal the presence of Aspergillus flavus in the tomb. Now, the same fungus linked to King Tut's tomb could have the capability to fight leukemia in a new form of cancer therapy. "There are a variety of compounds able to be produced by fungus," Gao told Fox News Digital. These compounds can be toxic to different cells, she noted, depending on the "biological management we are able to mitigate." The study aimed to find a specific kind of compound — ribosomally synthesized and post-translationally modified peptides, or "RiPPs" — within Aspergillus flavus, which was previously shown to be a good source. When this compound is able to enter cancer cells, Gao said, it may be able to stop their growth. "Cancer cells divide uncontrollably," Gao said in the release. "These compounds block the formation of microtubules, which are essential for cell division." When mixed with human cancer cells, two variants of the molecules within these RiPPS were found to have potent effects against leukemia cells, the researchers found. Another variant performed as well as two FDA-approved drugs that have been used for decades to treat leukemia (cytarabine and daunorubicin). Tiffany Troso-Sandoval, M.D., a medical oncologist and cancer care consultant based in New York, cautioned that this study, which was performed on cell cultures, is still in the very early stages. "It's still very far away from being applicable to use in humans with leukemia," Troso-Sandoval, who was not involved in the study, told Fox News Digital. Speaking about RiPPs, the doctor told Fox News Digital, "What they're referring to [in the study] is basically a rare type of bioactive molecule that they have isolated from this fungus." There are multiple subtypes of leukemia, Troso-Sandoval pointed out, including acute and chronic forms. "One treatment might not work on [another] type of leukemia," she noted. Further testing is needed to determine which subtypes may contain the active molecule. The compound explored in the study had little to no effect on breast, liver or lung cancer cells, the researchers noted. This suggests that its disruptive effects only work on certain types of cells, which will be an important consideration when developing medications. Looking ahead, the researchers plan to test the fungus' potential in animal models and, ultimately, human trials. Gao told Fox News Digital she is "excited about what nature can create and how it can benefit our society." For more Health articles, visit The study received support from the National Institutes of Health, the University of Pennsylvania, the Welch Foundation, the Houston Area Molecular Biophysics Program, the Cancer Prevention and Research Institute of Texas and the National Science Foundation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store